端到端体内基因编辑技术与药物开发与生产商
2025.09.30, 西藏药业, 康哲药业
2025.08.28, 康哲药业, 西藏药业
2021.09.01, 君联资本, Cormorant Asset Management
Note: collected from public online reports, for reference only.